Burrows Scott L
Chief Financial Officer · 19 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-01 | SYRE | Spyre Therapeutics, Inc. | Sale | 5,775 | $87.55 | $505,601.25 | filing |
| 2026-07-01 | SYRE | Spyre Therapeutics, Inc. | Sale | 1,725 | $88.37 | $152,438.25 | filing |
| 2026-07-01 | SYRE | Spyre Therapeutics, Inc. | Option exercise | 7,500 | $14.50 | $108,750.00 | filing |
| 2026-06-25 | SYRE | Spyre Therapeutics, Inc. | Sale | 10,000 | $87.14 | $871,400.00 | filing |
| 2026-06-25 | SYRE | Spyre Therapeutics, Inc. | Sale | 5,000 | $87.12 | $435,600.00 | filing |
| 2026-06-25 | SYRE | Spyre Therapeutics, Inc. | Option exercise | 15,000 | $14.50 | $217,500.00 | filing |
| 2026-06-01 | SYRE | Spyre Therapeutics, Inc. | Sale | 3,100 | $72.06 | $223,386.00 | filing |
| 2026-06-01 | SYRE | Spyre Therapeutics, Inc. | Sale | 2,599 | $70.77 | $183,931.23 | filing |
| 2026-06-01 | SYRE | Spyre Therapeutics, Inc. | Sale | 1,801 | $69.75 | $125,619.75 | filing |
| 2026-06-01 | SYRE | Spyre Therapeutics, Inc. | Option exercise | 7,500 | $14.50 | $108,750.00 | filing |
| 2026-05-01 | SYRE | Spyre Therapeutics, Inc. | Sale | 12,500 | $71.37 | $892,125.00 | filing |
| 2026-05-01 | SYRE | Spyre Therapeutics, Inc. | Option exercise | 12,500 | $14.50 | $181,250.00 | filing |
| 2026-04-01 | SYRE | Spyre Therapeutics, Inc. | Sale | 6,200 | $49.21 | $305,102.00 | filing |
| 2026-04-01 | SYRE | Spyre Therapeutics, Inc. | Option exercise | 7,500 | $14.50 | $108,750.00 | filing |
| 2026-04-01 | SYRE | Spyre Therapeutics, Inc. | Sale | 1,300 | $49.98 | $64,974.00 | filing |
| 2026-03-03 | SYRE | Spyre Therapeutics, Inc. | Sale | 2,300 | $40.56 | $93,288.00 | filing |
| 2026-03-03 | SYRE | Spyre Therapeutics, Inc. | Option exercise | 2,500 | $14.50 | $36,250.00 | filing |
| 2026-03-03 | SYRE | Spyre Therapeutics, Inc. | Sale | 200 | $41.66 | $8,332.00 | filing |
| 2025-09-02 | SYRE | Spyre Therapeutics, Inc. | Sale | 18,428 | $16.26 | $299,639.28 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.